# Effects of Restrictive Fluid Strategy on Postoperative Oliguric Pancreatic Surgery Patients

> **NCT03553394** · NA · TERMINATED · sponsor: **Uppsala University** · enrollment: 53 (actual)

## Conditions studied

- Fluid Therapy
- Postoperative Period
- Postoperative Complications
- Pancreas Disease
- Fluid Overload

## Interventions

- **DRUG:** Ringer's Acetate

## Key facts

- **NCT ID:** NCT03553394
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-10-01
- **Primary completion:** 2021-05-31
- **Final completion:** 2022-08-30
- **Target enrollment:** 53 (ACTUAL)
- **Why stopped:** Stopped after interim analysis
- **Last updated:** 2022-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03553394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03553394, "Effects of Restrictive Fluid Strategy on Postoperative Oliguric Pancreatic Surgery Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03553394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*